Illumina (LTS:0J8Z) Short-Term Debt : $499 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Illumina Short-Term Debt?

Illumina's Short-Term Debt for the quarter that ended in Dec. 2024 was $499 Mil.

Illumina's quarterly Short-Term Debt declined from Jun. 2024 ($744 Mil) to Sep. 2024 ($0 Mil) but then increased from Sep. 2024 ($0 Mil) to Dec. 2024 ($499 Mil).

Illumina's annual Short-Term Debt declined from Dec. 2022 ($1,248 Mil) to Dec. 2023 ($0 Mil) but then increased from Dec. 2023 ($0 Mil) to Dec. 2024 ($499 Mil).

Illumina Short-Term Debt Historical Data

The historical data trend for Illumina's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Short-Term Debt Chart

Illumina Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

511.00

1,248.00

499.00

Illumina Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															-	-	744.00	-	499.00

Illumina Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Illumina Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Illumina's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (LTS:0J8Z) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany I1LM34:Brazil ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina Headlines

No Headlines